Please assess the completion status of the following clinical trial:

Trial Title: Mindfulness to Improve Elders' Immune and Health Status

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 65 or older~* English speaking~* If prescribed antidepressant or anxiolytic medications, must have maintained a stable regimen for eight weeks prior to enrolling~Exclusion Criteria:~* receiving immunosuppressive therapy for cancer or other diseases~* major, uncorrected sensory impairments~* cognitive deficits (MMSE \<25, or deficits deemed significant enough to interfere)~* history of a psychotic disorder, bipolar disorder, organic brain syndrome, or mental retardation~* alcohol or substance abuse within the previous year~* severe cardiovascular disease~* known allergies to shellfish

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mindfulness-Based Stress Reduction (Type: ACTIVE_COMPARATOR): Participation in the Mindfulness-Based Stress Reduction (MBSR) program following the initial assessment period, just prior to the start of the immunological measures.
- Wait-list control (Type: NO_INTERVENTION): Wait-list control participants were offered MBSR training after completion of their primary assessments periods.

Based on this trial design, predict the completion outcome and termination type (if applicable).